These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 26475970)
21. Poly-(lactic-co-glycolic-acid)-based particulate vaccines: particle uptake by dendritic cells is a key parameter for immune activation. Silva AL; Rosalia RA; Varypataki E; Sibuea S; Ossendorp F; Jiskoot W Vaccine; 2015 Feb; 33(7):847-54. PubMed ID: 25576216 [TBL] [Abstract][Full Text] [Related]
22. CD8- dendritic cells and macrophages cross-present poly(D,L-lactate-co-glycolate) acid microsphere-encapsulated antigen in vivo. Schliehe C; Redaelli C; Engelhardt S; Fehlings M; Mueller M; van Rooijen N; Thiry M; Hildner K; Weller H; Groettrup M J Immunol; 2011 Sep; 187(5):2112-21. PubMed ID: 21795597 [TBL] [Abstract][Full Text] [Related]
23. Influence of surface charge of PLGA particles of recombinant hepatitis B surface antigen in enhancing systemic and mucosal immune responses. Thomas C; Gupta V; Ahsan F Int J Pharm; 2009 Sep; 379(1):41-50. PubMed ID: 19524654 [TBL] [Abstract][Full Text] [Related]
24. Characterization of poly(D,L-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells. Elamanchili P; Diwan M; Cao M; Samuel J Vaccine; 2004 Jun; 22(19):2406-12. PubMed ID: 15193402 [TBL] [Abstract][Full Text] [Related]
25. Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulation. Wang Q; Tan MT; Keegan BP; Barry MA; Heffernan MJ Biomaterials; 2014 Sep; 35(29):8385-93. PubMed ID: 24986256 [TBL] [Abstract][Full Text] [Related]
26. Ovalbumin peptide encapsulated in poly(d,l lactic-co-glycolic acid) microspheres is capable of inducing a T helper type 1 immune response. Newman KD; Samuel J; Kwon G J Control Release; 1998 Jun; 54(1):49-59. PubMed ID: 9741903 [TBL] [Abstract][Full Text] [Related]
27. PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines. Waeckerle-Men Y; Groettrup M Adv Drug Deliv Rev; 2005 Jan; 57(3):475-82. PubMed ID: 15560953 [TBL] [Abstract][Full Text] [Related]
28. PLGA microspheres encapsulating siRNA. De Rosa G; Salzano G Methods Mol Biol; 2015; 1218():43-51. PubMed ID: 25319645 [TBL] [Abstract][Full Text] [Related]
29. Combined DNA vaccine encapsulated in microspheres enhanced protection efficacy against Mycobacterium tuberculosis infection of mice. Cai H; Hu XD; Yu DH; Li SX; Tian X; Zhu YX Vaccine; 2005 Jul; 23(32):4167-74. PubMed ID: 15908060 [TBL] [Abstract][Full Text] [Related]
31. Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery. Chong CS; Cao M; Wong WW; Fischer KP; Addison WR; Kwon GS; Tyrrell DL; Samuel J J Control Release; 2005 Jan; 102(1):85-99. PubMed ID: 15653136 [TBL] [Abstract][Full Text] [Related]
32. The nanomaterial-dependent modulation of dendritic cells and its potential influence on therapeutic immunosuppression in lupus. Look M; Saltzman WM; Craft J; Fahmy TM Biomaterials; 2014 Jan; 35(3):1089-95. PubMed ID: 24183697 [TBL] [Abstract][Full Text] [Related]
33. Preparation and evaluation of a novel bioactive glass/lysozyme/PLGA composite microsphere. Liu H; Shi S; Cao J; Ji L; He Y; Xi J Drug Dev Ind Pharm; 2015 Mar; 41(3):458-63. PubMed ID: 24471512 [TBL] [Abstract][Full Text] [Related]
34. Surface modification of poly(D,L-lactic-co-glycolic acid) nanoparticles with protamine enhanced cross-presentation of encapsulated ovalbumin by bone marrow-derived dendritic cells. Han R; Zhu J; Yang X; Xu H J Biomed Mater Res A; 2011 Jan; 96(1):142-9. PubMed ID: 21105162 [TBL] [Abstract][Full Text] [Related]
35. Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice. Bivas-Benita M; Lin MY; Bal SM; van Meijgaarden KE; Franken KL; Friggen AH; Junginger HE; Borchard G; Klein MR; Ottenhoff TH Vaccine; 2009 Jun; 27(30):4010-7. PubMed ID: 19389445 [TBL] [Abstract][Full Text] [Related]
36. Preparation and characteristics of interferon-alpha poly(lactic-co-glycolic acid) microspheres. Yang F; Song FL; Pan YF; Wang ZY; Yang YQ; Zhao YM; Liang SZ; Zhang YM J Microencapsul; 2010; 27(2):133-41. PubMed ID: 20121486 [TBL] [Abstract][Full Text] [Related]
37. Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity. Pawar D; Mangal S; Goswami R; Jaganathan KS Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):550-9. PubMed ID: 23831265 [TBL] [Abstract][Full Text] [Related]
38. Stabilization and immune response of HBsAg encapsulated within poly(lactic-co-glycolic acid) microspheres using HSA as a stabilizer. Xu W; He J; Wu G; Xiong F; Du H; Wang G Int J Pharm; 2015 Dec; 496(2):332-41. PubMed ID: 26453785 [TBL] [Abstract][Full Text] [Related]